Tempo Scan Pacific Tbk Market Cap ($636.87 Million)
Market Cap & Net Worth: Tempo Scan Pacific Tbk (TSPC)
Tempo Scan Pacific Tbk market cap. Tempo Scan Pacific Tbk (JK:TSPC) has a market capitalization of $636.87 Million (Rp10.87 Trillion) as of November 1, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #10651 globally and #104 in its home market, demonstrating a -4.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tempo Scan Pacific Tbk's stock price Rp2410.00 by its total outstanding shares 4509864300 (4.51 Billion). Also see Tempo Scan Pacific Tbk cash conversion from operations for how efficiently the company converts equity into cash flow.
Tempo Scan Pacific Tbk Market Cap History (2015–2026)
Tempo Scan Pacific Tbk market cap history from 2015 to 2026. Data shows growth from $316.23 Million to $636.87 Million (7.00% CAGR). Check TSPC stock price for real-time trading data and today's change.
Index Memberships
Tempo Scan Pacific Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$412.24 Billion | 0.15% | #103 of 864 |
Weight: Tempo Scan Pacific Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tempo Scan Pacific Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tempo Scan Pacific Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Tempo Scan Pacific Tbk growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Tempo Scan Pacific Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Tempo Scan Pacific Tbk's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $316.23 Million | $8.18 Trillion | $521.96 Billion | 0.00x | 0.00x |
| 2016 | $366.24 Million | $9.14 Trillion | $536.27 Billion | 0.00x | 0.00x |
| 2017 | $343.22 Million | $9.57 Trillion | $543.80 Billion | 0.00x | 0.00x |
| 2018 | $271.75 Million | $10.09 Trillion | $512.03 Billion | 0.00x | 0.00x |
| 2019 | $279.63 Million | $10.99 Trillion | $554.26 Billion | 0.00x | 0.00x |
| 2020 | $291.03 Million | $10.97 Trillion | $787.80 Billion | 0.00x | 0.00x |
| 2021 | $329.20 Million | $11.23 Trillion | $823.77 Billion | 0.00x | 0.00x |
| 2022 | $326.28 Million | $12.25 Trillion | $1.00 Trillion | 0.00x | 0.00x |
| 2023 | $466.73 Million | $13.12 Trillion | $1.18 Trillion | 0.00x | 0.00x |
| 2024 | $660.65 Million | $13.65 Trillion | $1.45 Trillion | 0.00x | 0.00x |
Competitor Companies of TSPC by Market Capitalization
Companies near Tempo Scan Pacific Tbk in the global market cap rankings as of November 1, 2026. Also see how large is Tempo Scan Pacific Tbk's balance sheet for a full breakdown of the balance sheet.
Key companies related to Tempo Scan Pacific Tbk by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Tempo Scan Pacific Tbk (2015–2026)
Market capitalization of Tempo Scan Pacific Tbk from 2015 to today. Between 2015 and today, Tempo Scan Pacific Tbk's market cap moved from $316.23 Million to $ 636.87 Million, with a yearly change of 7.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp636.87 Million | -15.44% |
| 2025 | Rp753.14 Million | +14.00% |
| 2024 | Rp660.65 Million | +41.55% |
| 2023 | Rp466.73 Million | +43.05% |
| 2022 | Rp326.28 Million | -0.88% |
| 2021 | Rp329.20 Million | +13.12% |
| 2020 | Rp291.03 Million | +4.08% |
| 2019 | Rp279.63 Million | +2.90% |
| 2018 | Rp271.75 Million | -20.82% |
| 2017 | Rp343.22 Million | -6.29% |
| 2016 | Rp366.24 Million | +15.82% |
| 2015 | Rp316.23 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Tempo Scan Pacific Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $636.87 Million USD |
| MoneyControl | $636.87 Million USD |
| MarketWatch | $636.87 Million USD |
| marketcap.company | $636.87 Million USD |
| Reuters | $636.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and… Read more